| abstract |
The present disclosure is useful in the treatment of Pyrazole virus infections, including infections caused by HIV virus, N-((S) -1- (3- (4-chloro-3- (methylsulfonamide) -1-). 2,2,2-Trifluoroethyl) -1H-indazole-7-yl) -6- (3-methyl-3- (methylsulfonyl) buta-1-in-1-yl) pyridin-2-yl)- 2- (3,5-difluorophenyl) ethyl) -2-((3bS, 4aR) -5,5-difluoro-3- (trifluoromethyl) -3b, 4,4a, 5-tetrahydro-1H-cyclopropa [ 3,4] With respect to the pharmaceutically acceptable salt, co-crystal, and crystal form of the compound which is cyclopenta [1,2-c] pyrazole-1-yl) acetamide. |